|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with IL15R x IL-2 x CD20
100 Translational Medicine associated with IL15R x IL-2 x CD20
0 Patents (Medical) associated with IL15R x IL-2 x CD20